Related Experiment Video
Updated: Apr 6, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
ADAMTS13 and von Willebrand factor interactions
Catherine B Zander1, Wenjing Cao, X Long Zheng
1Division of Laboratory Medicine, Department of Pathology, The University of Alabama at Birmingham, Birmingham, Alabama, USA.
Understanding the ADAMTS13-VWF interaction is key to treating thrombotic thrombocytopenic purpura (TTP). Recent studies reveal crucial structural elements of ADAMTS13 involved in VWF binding and TTP mechanisms.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- ADAMTS13 is a metalloprotease essential for cleaving von Willebrand factor (VWF).
- Deficiency in ADAMTS13 activity causes thrombotic thrombocytopenic purpura (TTP), a life-threatening blood disorder.
Purpose of the Study:
- To elucidate the intricate structure-function relationship of ADAMTS13 in VWF interaction.
- To explore novel therapeutic targets for TTP by understanding ADAMTS13-VWF binding mechanisms.
Main Methods:
- Analysis of ADAMTS13 domains (metalloprotease, disintegrin, TSP-1 repeats, CUB domains) and their role in VWF cleavage.
- Fine mapping of anti-ADAMTS13 antibody epitopes to identify key structural elements for VWF binding.
- Investigating the regulatory functions of distal ADAMTS13 domains.
Main Results:
- Specific regions within the disintegrin, cysteine-rich, and spacer domains are critical for VWF interaction.
- Distal domains (TSP-1 2-8 repeats, CUB domains) may play regulatory roles in ADAMTS13 function.
- Epitope mapping provides insights into structural elements essential for VWF binding and autoantibody-mediated TTP.
Conclusions:
- Significant advancements have been made in understanding ADAMTS13 structure-function over the last decade.
- Further research on ADAMTS13-VWF interactions under physiological in vivo conditions is crucial for medical applications.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Intracellular Signaling Affects Focal Adhesions
Some...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

